Wang, Kevin Y. X.
Pupo, Gulietta M.
Tembe, Varsha
Patrick, Ellis
Strbenac, Dario
Schramm, Sarah-Jane
Thompson, John F.
Scolyer, Richard A. http://orcid.org/0000-0002-8991-0013
Muller, Samuel http://orcid.org/0000-0002-3087-8127
Tarr, Garth http://orcid.org/0000-0002-6605-7478
Mann, Graham J.
Yang, Jean Y. H. http://orcid.org/0000-0002-5271-2603
Article History
Received: 10 November 2021
Accepted: 19 May 2022
First Online: 4 July 2022
Competing interests
: R.A.S. has received fees for professional services from F. Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, MSD Sharp & Dohme, NeraCare, AMGEN., Bristol-Myers Squibb, Myriad Genetics, GlaxoSmithKline. J.F.T. has received honoraria for advisory board participation from BMS Australia, MSD Australia, GlaxoSmithKline and Provectus Inc, and travel support from GlaxoSmithKline and Provectus Inc. All other authors declare no competing interests.